We reported previously that silencing LDHB in KRAS-mutant lung cancer cell lines significantly reduced the expression of SLC7A1111, which is required for oncogenic RAS transformation and encodes a plasma membrane-localized cystine/glutamate antiporter that provides cysteine for GSH synthesis22,23. Here, KRAS is linked to lung carcinoma.